Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Migraine Disorders | 32 | 2018 | 68 | 5.150 |
Why?
|
| Headache | 34 | 2017 | 72 | 4.440 |
Why?
|
| Behavior Therapy | 18 | 2015 | 103 | 2.910 |
Why?
|
| Tension-Type Headache | 12 | 2015 | 14 | 2.290 |
Why?
|
| Headache Disorders | 14 | 2012 | 17 | 1.760 |
Why?
|
| Stress, Psychological | 12 | 2017 | 229 | 1.270 |
Why?
|
| Biofeedback, Psychology | 9 | 2015 | 12 | 1.130 |
Why?
|
| Research Design | 12 | 2013 | 316 | 1.050 |
Why?
|
| Mental Disorders | 9 | 2009 | 115 | 1.020 |
Why?
|
| Humans | 87 | 2020 | 32278 | 0.770 |
Why?
|
| Exercise | 4 | 2017 | 605 | 0.720 |
Why?
|
| Biomedical Research | 4 | 2018 | 178 | 0.650 |
Why?
|
| Headache Disorders, Primary | 2 | 2009 | 3 | 0.550 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 854 | 0.530 |
Why?
|
| Pain | 4 | 2012 | 303 | 0.490 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 180 | 0.480 |
Why?
|
| Back Pain | 4 | 2020 | 25 | 0.460 |
Why?
|
| Relaxation Therapy | 6 | 2015 | 13 | 0.410 |
Why?
|
| Clinical Trials as Topic | 4 | 2005 | 312 | 0.410 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2019 | 545 | 0.400 |
Why?
|
| Exercise Therapy | 1 | 2015 | 249 | 0.400 |
Why?
|
| Models, Biological | 1 | 2015 | 408 | 0.390 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 90 | 0.360 |
Why?
|
| Chronic Disease | 11 | 2010 | 411 | 0.340 |
Why?
|
| Anxiety Disorders | 3 | 2008 | 72 | 0.330 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 73 | 0.310 |
Why?
|
| Research | 5 | 2005 | 81 | 0.310 |
Why?
|
| Models, Theoretical | 3 | 2017 | 139 | 0.300 |
Why?
|
| Adult | 32 | 2019 | 9258 | 0.300 |
Why?
|
| Depressive Disorder | 2 | 2008 | 69 | 0.270 |
Why?
|
| Comorbidity | 6 | 2012 | 563 | 0.270 |
Why?
|
| Sleep | 1 | 2008 | 87 | 0.260 |
Why?
|
| Manipulation, Osteopathic | 1 | 2007 | 1 | 0.260 |
Why?
|
| Relaxation | 1 | 2007 | 9 | 0.250 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2007 | 24 | 0.250 |
Why?
|
| Patient Selection | 2 | 2005 | 272 | 0.250 |
Why?
|
| Double-Blind Method | 2 | 2005 | 567 | 0.240 |
Why?
|
| Sexuality | 1 | 2006 | 14 | 0.240 |
Why?
|
| Pain Measurement | 6 | 2019 | 339 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 2 | 2006 | 395 | 0.230 |
Why?
|
| Middle Aged | 26 | 2019 | 11844 | 0.230 |
Why?
|
| Neuropsychology | 1 | 2005 | 3 | 0.220 |
Why?
|
| Neuropsychological Tests | 2 | 2005 | 329 | 0.220 |
Why?
|
| Female | 32 | 2019 | 19949 | 0.220 |
Why?
|
| Sexual Behavior | 1 | 2006 | 131 | 0.220 |
Why?
|
| Adolescent | 12 | 2017 | 3516 | 0.220 |
Why?
|
| Cognition | 2 | 2008 | 549 | 0.220 |
Why?
|
| Psychotherapy | 3 | 2019 | 20 | 0.210 |
Why?
|
| Chest Pain | 1 | 2007 | 205 | 0.210 |
Why?
|
| Male | 30 | 2019 | 19443 | 0.210 |
Why?
|
| Electroencephalography | 1 | 2003 | 75 | 0.190 |
Why?
|
| Treatment Outcome | 8 | 2020 | 3407 | 0.180 |
Why?
|
| Psychotherapy, Group | 1 | 2002 | 15 | 0.180 |
Why?
|
| Placebos | 1 | 2002 | 68 | 0.180 |
Why?
|
| Disease Progression | 4 | 2017 | 591 | 0.180 |
Why?
|
| Caffeine | 1 | 2002 | 28 | 0.180 |
Why?
|
| Central Nervous System Stimulants | 1 | 2002 | 82 | 0.170 |
Why?
|
| Recurrence | 8 | 2005 | 286 | 0.170 |
Why?
|
| Telemedicine | 2 | 2019 | 122 | 0.160 |
Why?
|
| Patient Compliance | 3 | 2006 | 206 | 0.160 |
Why?
|
| Low Back Pain | 1 | 2020 | 41 | 0.160 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 880 | 0.150 |
Why?
|
| Cluster Analysis | 2 | 1999 | 120 | 0.150 |
Why?
|
| Nurses | 1 | 2019 | 14 | 0.150 |
Why?
|
| Bioethics | 1 | 2018 | 2 | 0.140 |
Why?
|
| Authorship | 1 | 2018 | 9 | 0.140 |
Why?
|
| Publications | 1 | 2018 | 9 | 0.140 |
Why?
|
| Minority Groups | 1 | 2018 | 81 | 0.140 |
Why?
|
| Health Personnel | 1 | 2019 | 112 | 0.140 |
Why?
|
| Poverty | 1 | 2018 | 105 | 0.130 |
Why?
|
| Telephone | 1 | 2018 | 61 | 0.130 |
Why?
|
| Adaptation, Psychological | 2 | 2014 | 134 | 0.120 |
Why?
|
| Population Surveillance | 2 | 2017 | 120 | 0.120 |
Why?
|
| Remission Induction | 2 | 2013 | 92 | 0.120 |
Why?
|
| Risk Factors | 7 | 2013 | 3936 | 0.120 |
Why?
|
| Aged | 11 | 2019 | 10256 | 0.120 |
Why?
|
| Secondary Prevention | 2 | 2009 | 73 | 0.120 |
Why?
|
| Meta-Analysis as Topic | 4 | 2005 | 47 | 0.120 |
Why?
|
| Depression | 4 | 2019 | 427 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2005 | 471 | 0.110 |
Why?
|
| Longitudinal Studies | 3 | 2013 | 760 | 0.110 |
Why?
|
| Young Adult | 4 | 2017 | 2651 | 0.110 |
Why?
|
| Prevalence | 3 | 2013 | 955 | 0.110 |
Why?
|
| Socioenvironmental Therapy | 1 | 1994 | 1 | 0.100 |
Why?
|
| Complementary Therapies | 1 | 2014 | 44 | 0.100 |
Why?
|
| Propranolol | 2 | 1991 | 17 | 0.100 |
Why?
|
| Thinking | 1 | 2013 | 8 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 48 | 0.100 |
Why?
|
| Precipitating Factors | 1 | 2013 | 1 | 0.100 |
Why?
|
| Data Collection | 1 | 2013 | 171 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2013 | 154 | 0.090 |
Why?
|
| United States | 2 | 2018 | 4074 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2012 | 174 | 0.090 |
Why?
|
| Age Distribution | 1 | 2012 | 194 | 0.090 |
Why?
|
| Forecasting | 2 | 2017 | 144 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 1484 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 109 | 0.080 |
Why?
|
| Health Expenditures | 1 | 2011 | 66 | 0.080 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2010 | 6 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 1990 | 54 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2011 | 184 | 0.080 |
Why?
|
| Analgesics | 1 | 2011 | 111 | 0.080 |
Why?
|
| Muscle Contraction | 3 | 2008 | 175 | 0.080 |
Why?
|
| Home Nursing | 1 | 2009 | 9 | 0.070 |
Why?
|
| Anxiety | 2 | 2009 | 195 | 0.070 |
Why?
|
| North Carolina | 1 | 2012 | 1300 | 0.070 |
Why?
|
| Electromyography | 2 | 2008 | 67 | 0.070 |
Why?
|
| Persuasive Communication | 1 | 2007 | 3 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2007 | 167 | 0.060 |
Why?
|
| Truth Disclosure | 1 | 2007 | 14 | 0.060 |
Why?
|
| Heart Rate | 3 | 1985 | 364 | 0.060 |
Why?
|
| Personality Inventory | 3 | 2003 | 15 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 1 | 2006 | 23 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2006 | 31 | 0.060 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2006 | 28 | 0.060 |
Why?
|
| Serotonin | 1 | 2006 | 44 | 0.060 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2006 | 55 | 0.060 |
Why?
|
| Hormones | 1 | 2005 | 24 | 0.060 |
Why?
|
| Menstrual Cycle | 1 | 2005 | 32 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2005 | 57 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 179 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2006 | 173 | 0.060 |
Why?
|
| Time Factors | 5 | 2013 | 2203 | 0.060 |
Why?
|
| Psychological Tests | 1 | 1985 | 31 | 0.050 |
Why?
|
| Arousal | 2 | 1994 | 21 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 72 | 0.050 |
Why?
|
| Photophobia | 2 | 2005 | 2 | 0.050 |
Why?
|
| Motor Activity | 1 | 2006 | 332 | 0.050 |
Why?
|
| Coronary Disease | 2 | 1996 | 226 | 0.050 |
Why?
|
| Nausea | 2 | 2005 | 50 | 0.050 |
Why?
|
| Periodicity | 1 | 2002 | 11 | 0.050 |
Why?
|
| Animals | 3 | 2010 | 8197 | 0.050 |
Why?
|
| Disability Evaluation | 2 | 2019 | 241 | 0.050 |
Why?
|
| Women's Health | 2 | 2002 | 230 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2005 | 349 | 0.050 |
Why?
|
| Lead Poisoning | 1 | 1982 | 2 | 0.050 |
Why?
|
| Saliva | 1 | 2002 | 41 | 0.040 |
Why?
|
| Affect | 1 | 2002 | 75 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2002 | 72 | 0.040 |
Why?
|
| Hand | 1 | 2002 | 81 | 0.040 |
Why?
|
| Reaction Time | 1 | 2002 | 123 | 0.040 |
Why?
|
| Diagnosis-Related Groups | 1 | 2001 | 9 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2002 | 108 | 0.040 |
Why?
|
| Learning | 1 | 1982 | 84 | 0.040 |
Why?
|
| Psychometrics | 2 | 1996 | 137 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 245 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 1840 | 0.040 |
Why?
|
| Desipramine | 1 | 2020 | 8 | 0.040 |
Why?
|
| Self Care | 2 | 2006 | 97 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 716 | 0.040 |
Why?
|
| Societies, Medical | 2 | 1999 | 153 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 1212 | 0.040 |
Why?
|
| Hyperacusis | 1 | 1999 | 1 | 0.040 |
Why?
|
| Vomiting | 1 | 1999 | 20 | 0.040 |
Why?
|
| Scientific Misconduct | 1 | 2018 | 4 | 0.040 |
Why?
|
| Conflict of Interest | 1 | 2018 | 34 | 0.040 |
Why?
|
| Awareness | 1 | 2018 | 23 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 1999 | 195 | 0.030 |
Why?
|
| Sick Role | 2 | 1996 | 7 | 0.030 |
Why?
|
| Progesterone | 2 | 2002 | 78 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2002 | 866 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2018 | 192 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 556 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 90 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2001 | 52 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 246 | 0.030 |
Why?
|
| Child | 1 | 2003 | 2431 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 230 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2019 | 329 | 0.030 |
Why?
|
| Overweight | 1 | 2017 | 252 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2012 | 3610 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2017 | 179 | 0.030 |
Why?
|
| International Cooperation | 2 | 2012 | 31 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1994 | 20 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 367 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2002 | 501 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 2238 | 0.020 |
Why?
|
| Probability | 1 | 2013 | 155 | 0.020 |
Why?
|
| Menstruation Disturbances | 1 | 1992 | 5 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 476 | 0.020 |
Why?
|
| Parturition | 1 | 2012 | 9 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 650 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2012 | 36 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 128 | 0.020 |
Why?
|
| Estradiol | 1 | 1992 | 139 | 0.020 |
Why?
|
| Poloxalene | 1 | 2011 | 1 | 0.020 |
Why?
|
| Drug Costs | 1 | 2011 | 46 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 1992 | 130 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 106 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 550 | 0.020 |
Why?
|
| Obesity | 1 | 2017 | 1111 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 1990 | 27 | 0.020 |
Why?
|
| Ergotamine | 1 | 1989 | 1 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 743 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2005 | 287 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 960 | 0.020 |
Why?
|
| Internal-External Control | 2 | 1985 | 14 | 0.020 |
Why?
|
| Sex Factors | 2 | 2002 | 656 | 0.020 |
Why?
|
| Headache Disorders, Secondary | 1 | 2007 | 2 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 1996 | 756 | 0.020 |
Why?
|
| Treatment Refusal | 1 | 2007 | 14 | 0.020 |
Why?
|
| Smoking | 1 | 1991 | 505 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2006 | 21 | 0.020 |
Why?
|
| Reminder Systems | 1 | 2006 | 23 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2006 | 74 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 191 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 16 | 0.010 |
Why?
|
| Environment | 1 | 1985 | 47 | 0.010 |
Why?
|
| Prognosis | 2 | 2005 | 1529 | 0.010 |
Why?
|
| Personality Disorders | 1 | 2005 | 5 | 0.010 |
Why?
|
| Observation | 1 | 2005 | 22 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 212 | 0.010 |
Why?
|
| Sample Size | 1 | 2005 | 38 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2005 | 74 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2005 | 99 | 0.010 |
Why?
|
| Medical Records | 1 | 2005 | 75 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 187 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1982 | 34 | 0.010 |
Why?
|
| Locomotion | 1 | 1982 | 34 | 0.010 |
Why?
|
| Prejudice | 1 | 2002 | 45 | 0.010 |
Why?
|
| Social Class | 1 | 2002 | 90 | 0.010 |
Why?
|
| Pain Clinics | 1 | 2001 | 1 | 0.010 |
Why?
|
| Migraine without Aura | 1 | 2001 | 1 | 0.010 |
Why?
|
| Migraine with Aura | 1 | 2001 | 2 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2001 | 44 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 91 | 0.010 |
Why?
|
| Estrogens | 1 | 2002 | 194 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 2317 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2002 | 242 | 0.010 |
Why?
|
| Vascular Headaches | 1 | 1998 | 1 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1982 | 624 | 0.010 |
Why?
|
| Rats | 1 | 1982 | 1895 | 0.010 |
Why?
|
| Type A Personality | 1 | 1996 | 1 | 0.010 |
Why?
|
| Continental Population Groups | 1 | 1998 | 228 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1996 | 42 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1996 | 83 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 1994 | 76 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1994 | 100 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2001 | 3898 | 0.010 |
Why?
|
| Software Validation | 1 | 1992 | 4 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 39 | 0.010 |
Why?
|
| Quality of Life | 1 | 1998 | 969 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1991 | 77 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1992 | 555 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1994 | 466 | 0.000 |
Why?
|